Skip to content

Polyunsaturated Fatty Acids-based Bars Effect on Metabolic Syndrome Patients

Effects of Polyunsaturated Fatty Acids-based Bars on Lipid Profile Among Patients With Metabolic Syndrome

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07627555
Enrollment
60
Registered
2026-06-04
Start date
2025-02-06
Completion date
2025-07-16
Last updated
2026-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia, Metabolic Syndrome (MetS)

Keywords

lipid profile, omega 3 fatty acids, metabolic syndrome, cardiovascular diseases, poly unsaturated fatty acids

Brief summary

This study aimed to manage dyslipidemia through Polyunsaturated fatty acids based bar among patients with metabolic syndrome.

Detailed description

This study was conducted at Chaudhry Muhammad Akram Teaching & Research Hospital, Lahore. Total 60 individuals diagnosed with metabolic syndrome, like deranged lipid profile, high blood pressure (ranges mild to moderate), and elevated levels of HbA1c (5.6%-6.4%), aged between 40 to 65 years were part of the study. The participants were randomly selected and divided into two groups. Control group (T 0 ) was given one jelly candy as mid-morning snack. The experimental group (T 1 ) was given PUFA bar one each daily The follow-up for patients has been conducted monthly, all laboratory test (blood pressure, lipid profile, HbA1c and CRP) has been done on 1st and after 8 weeks. The baseline and post-test study data is compared to test the study hypothesis.

Interventions

DIETARY_SUPPLEMENTJelly Candy

participants were advised to take one jelly candy as a mid-morning snack for a duration of 2 months.

DIETARY_SUPPLEMENTPUFA Bar

Participants were advised to taken one PUFA bar as a mid- morning snack for a duration of 2 months.

Sponsors

University of Lahore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Metabolic syndrome patient's age 40 to 65 years with BMI (above 25 kg/m 2 ) was major part of this study. * Patients having Triglyceride levels range from mild to moderate (150 to 499 mg/dL) are included in the study. * Patients having LDL (Low density lipoprotein) range from mild (130-159 mg/dL) to moderate (160-189 mg/dL) are included in the study. * Patients having HDL (High-density lipoprotein) range from mild to moderate (60 mg/dL or higher) have been included in the study.

Exclusion criteria

* Lactating and pregnant women will not be included. * Patients who are using any kind of medicine. * Any person allergic to nuts. * Adults suffering from critical health conditions, including cancer.

Design outcomes

Primary

MeasureTime frameDescription
Body Mass Index60 daysBMI is defined as body weight in kilograms divided by height in meters squared (kg/m²). BMI cut-off points are used to assess weight status, categorizing individuals as underweight, normal, overweight or obese. Obesity is further classified into grades 1, 2 and 3.
Lipid Profile60 daysTotal cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides levels were measured.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 5, 2026